ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 235,11
0,78%
Dow Jones
44 910,65
0,42%
DAX
19 626,45
1,05%
Brent Oil
71,98
-0,08%
Bitcoin
96 208,45
-1,31%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Alexion Pharmaceuticals Inc (ALXN)

  7. Alexion Pharmaceuticals Inc (ALXN) Actualités

ALXN

Alexion Pharmaceuticals (ALXN)

Alexion Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ALXN
DateHeureSourceTitreSymboleSociété
28/07/202310h54KR Market News알렉시온, 화이자 유전자 치료제를 10억 달러 인수 합의NASDAQ:ALXNAlexion Pharmaceuticals Inc
28/07/202310h23KR Market News아스트라제네카, 항암제 수요로 2분기 결과 예상치 상회NASDAQ:ALXNAlexion Pharmaceuticals Inc
26/07/202112h02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ALXNAlexion Pharmaceuticals Inc
23/07/202122h55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
22/07/202115h09Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ALXNAlexion Pharmaceuticals Inc
22/07/202112h27Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ALXNAlexion Pharmaceuticals Inc
21/07/202115h12Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:ALXNAlexion Pharmaceuticals Inc
16/07/202101h01PR Newswire (US)Moderna Set to Join S&P 500NASDAQ:ALXNAlexion Pharmaceuticals Inc
15/07/202122h05Business WireAlexion Announces Positive Topline Results from Phase 3 Study of ULTOMIRIS® (ravulizumab-cwvz) in Adults with Generalized My...NASDAQ:ALXNAlexion Pharmaceuticals Inc
15/07/202102h00GlobeNewswire Inc.Honeywell International Inc. to Join the NASDAQ-100 Index Beginning July 21, 2021NASDAQ:ALXNAlexion Pharmaceuticals Inc
14/07/202118h13Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:ALXNAlexion Pharmaceuticals Inc
14/07/202111h11Dow Jones NewsAstraZeneca Says $39 Billion Alexion Deal Set for Completion After UK Clearance -- UpdateNASDAQ:ALXNAlexion Pharmaceuticals Inc
14/07/202108h30Dow Jones NewsUK Regulator Clears AstraZeneca's Alexion DealNASDAQ:ALXNAlexion Pharmaceuticals Inc
11/06/202109h01Business WireCaelum & Alexion Present Additional Phase 2 Data Reinforcing Safety & Tolerability of CAEL-101 in AL Amyloidosis at the Europ...NASDAQ:ALXNAlexion Pharmaceuticals Inc
07/06/202119h55Business Wire Alexion Announces FDA Approval of ULTOMIRIS® (ravulizumab-cwvz) for Children & Adolescents with Paroxysmal Nocturnal Hemog...NASDAQ:ALXNAlexion Pharmaceuticals Inc
04/06/202122h22Dow Jones NewsAstraZeneca Taps Alexion Executive for CFO Job -- UpdateNASDAQ:ALXNAlexion Pharmaceuticals Inc
04/06/202108h40Dow Jones NewsAstraZeneca Names Aradhana Sarin as Next CFONASDAQ:ALXNAlexion Pharmaceuticals Inc
27/05/202108h43Dow Jones NewsAstraZeneca Prices EUR800 Million Bond OfferingNASDAQ:ALXNAlexion Pharmaceuticals Inc
26/05/202108h43Dow Jones NewsAstraZeneca Prices $7 Billion Bond Offering to Partly Fund Alexion AcquisitionNASDAQ:ALXNAlexion Pharmaceuticals Inc
25/05/202108h41Dow Jones NewsUK Watchdog Starts Investigation Into AstraZeneca's Acquisition of AlexionNASDAQ:ALXNAlexion Pharmaceuticals Inc
13/05/202114h06Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ALXNAlexion Pharmaceuticals Inc
12/05/202122h14Business WireCaelum and Alexion Announce Upcoming CAEL-101 Data Presentations at the European Hematology Association Congress 2021NASDAQ:ALXNAlexion Pharmaceuticals Inc
12/05/202122h01Business WireAlexion Announces Upcoming Data Presentations at the 26th European Hematology Association Virtual CongressNASDAQ:ALXNAlexion Pharmaceuticals Inc
12/05/202110h52TipRanksAlexion Investors Approve Acquisition By AstraZenecaNASDAQ:ALXNAlexion Pharmaceuticals Inc
11/05/202122h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ALXNAlexion Pharmaceuticals Inc
11/05/202115h28Business WireAlexion Shareholders Approve Acquisition by AstraZenecaNASDAQ:ALXNAlexion Pharmaceuticals Inc
30/04/202114h27Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ALXNAlexion Pharmaceuticals Inc
30/04/202114h00Business WireAlexion Reports First Quarter 2021 ResultsNASDAQ:ALXNAlexion Pharmaceuticals Inc
28/04/202123h00Business WireUPDATED Alexion to Report First Quarter 2021 Results on Friday, April 30, 2021NASDAQ:ALXNAlexion Pharmaceuticals Inc
20/04/202114h00Business WireAlexion to Report First Quarter 2021 Results on Monday, May 3, 2021NASDAQ:ALXNAlexion Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ALXN

Dernières Valeurs Consultées

AMEX
RHE
Regional Health Properties
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés

BLACK FRIDAY

ADVFN

Célébrons nos 25 ans Est 1999-2024

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres

Cours Euronext en temps réel et illimités sur le site. Carnet d'ordres Euronext en direct